Table 2.
Patient Demographics and Tumor Characteristics
| Number (%) N=2,573 |
|
|---|---|
| Patient Demographics | |
| Age (mean ±SD, years) | 73.8 ± 5.3 |
| Female | 1,400 (54.4) |
| Race | |
| White | 2,222 (86.4) |
| Black | 164 (6.4) |
| Hispanic | 30 (1.2) |
| Other | 157 (6.1) |
| Married | 1,578 (62.9) |
| Charlson comorbidity score | |
| 0 | 1136 (44.1) |
| 1 | 826 (32.1) |
| 2 | 360 (14.0) |
| 3+ | 251 (9.8) |
| SEER Region | |
| Atlanta | 88 (3.4) |
| Connecticut | 257 (10.0) |
| Detroit | 304 (11.8) |
| Greater California | 331 (12.9) |
| Hawaii | 57 (2.2) |
| Iowa | 181 (7.0) |
| Kentucky | 150 (5.8) |
| Los Angeles | 229 (8.9) |
| Louisiana | 125 (4.9) |
| New Jersey | 371 (14.4) |
| New Mexico | 62 (2.4) |
| San Francisco | 101 (3.9) |
| San Jose | 95 (3.7) |
| Seattle | 120 (4.7) |
| Utah | 99 (3.9) |
| Preoperative Signs/Symptoms | |
| Jaundice | 1650 (64.3) |
| Cholangitis | 265 (10.3) |
| Pruritis | 168 (6.5) |
| Coagulopathy | 17 (0.7) |
| Tumor Characteristics and Treatment | |
| Local/regional stage | 2,318 (90.1) |
| Tumor size in cm (N=2,269) | 3.3 ± 1.7 |
| Well/moderately differentiated | 1,414 (55.0) |
| Positive lymph nodes (N=2,304) | 1,402 (60.9) |
| Neoadjuvant therapy | 147 (5.7) |